课题基金 / 基金详情

COMPARE ANTIVIRAL EFFICACY OF ORALTDF & SUBCUTANEOUSTFV IN SIV-INFECTED MACAQUES

COMPARE ANTIVIRAL EFFICACY OF ORALTDF & SUBCUTANEOUSTFV IN SIV-INFECTED MACAQUES
比较 ORALTDF 的抗病毒功效
批准号:
8357301
负责人:
KOEN K VAN ROMPAY
金额:
$19.14万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-05-01 至 2012-04-30

项目摘要

项目成果

KOEN K VAN ROMPAY的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. The study will compare the antiviral efficacy and pharmacokinetics of the parenteral compound tenofovir and its prodrug tenofovir disoproxyl fumarate in groups of SIV-infected macaques.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
  • 批准号:
    10223632
  • 项目类别:
  • 资助金额:
    $88.69万
  • 财政年份:
    2020
  • 负责人:
    KOEN K VAN ROMPAY
  • 依托单位:
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
LONG-TERM SAFETY AND EFFICACY OF PMPA (TENOFOVIR)
  • 批准号:
    8357237
  • 项目类别:
  • 资助金额:
    $19.14万
  • 财政年份:
    2011
  • 负责人:
    KOEN K VAN ROMPAY
  • 依托单位:
LONG-TERM SAFETY AND EFFICACY OF PMPA (TENOFOVIR)
  • 批准号:
    8172504
  • 项目类别:
  • 资助金额:
    $15.21万
  • 财政年份:
    2010
  • 负责人:
    KOEN K VAN ROMPAY
  • 依托单位:
海外基金